AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
June 20 2008 - 9:35AM
PR Newswire (US)
NEW YORK, June 20 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL),
announced today it has retained Strategic Growth International,
Inc. ("SGI"), a global investor relations firm, to assist the
Company in growing its financial market presence. SGI will assist
the Company in establishing a stronger understanding of the
investment opportunity AMDL represents while increasing the
Company's awareness across global investment communities. Gary
Dreher, CEO of AMDL, commented, "As we continue building AMDL into
a world-class pharmaceutical company we feel strong communications
is imperative to our success. SGI has a strong reputation with an
exceptional team and we're excited to have them as a partner to
communicate our corporate story, the great progress we're making
with new products and technologies in the U.S., China, and other
global markets, and most important, how we intend to meet our
stated financial targets of doubling annual sales consecutively
over the next 3 years." SGI Co-Founder Rich Cooper also commented
saying, "We believe a strong investment story exists with AMDL and
we're excited the company has chosen us to support their IR
efforts. Through our combined efforts we will focus on achieving a
fair and sustainable market valuation for AMDL while enhancing
their reputation with investors, analysts, and the financial
media." Founded in 1989, SGI is headed by Richard E. Cooper and
Stanley Altschuler, both long-time and highly-respected Wall Street
veterans. Prior to his co-founding SGI, Mr. Cooper was a Managing
Director at Salomon Brothers for five of his 14 years at the firm.
Mr. Altschuler owned and managed a New York-based brokerage firm.
About AMDL AMDL, Inc. is a global specialty pharmaceutical company.
The Company is headquartered in Tustin, California with operations
in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary
Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research,
development, manufacture, and marketing of diagnostic,
pharmaceutical, nutritional supplement, and cosmetic products
currently in China. The company employs approximately 320 people in
the U.S. and China. More information about AMDL and its products
can be obtained at http://www.amdl.com/. Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a
safe harbor for forward-looking statements made by the Company or
on its behalf. This news release contains forward-looking
statements, which are subject to certain risks and uncertainties
that can cause actual results to differ materially from those
described. Factors that may cause such differences include, but are
not limited to, uncertainties relating to our ability to
successfully complete Phase III clinical trials and secure
regulatory approval of our current or future drug-delivery system
and uncertainties regarding our ability to obtain financial and
other resources for any research, development and commercialization
activities. These factors, and others, are discussed from time to
time in our filings with the Securities and Exchange Commission.
You should not place undue reliance on these forward-looking
statements, which speak only as of the date they are made. We
undertake no obligation to publicly update or revise these
forward-looking statements to reflect events or circumstances after
the date they are made. AMDL Contact: Investor Relations Contact:
Kristine Szarkowitz Strategic Growth International, Inc.
Director-Investor Relations Richard E. Cooper - Cass Almendral -
(206) 310-5323 (212) 838-1444/ http://www.sgi-ir.com/ DATASOURCE:
AMDL, Inc. CONTACT: Kristine Szarkowitz, Director-Investor
Relations of AMDL, Inc., +1-206-310-5323; or investor relations,
Richard E. Cooper, , or Cass Almendral, , both of Strategic Growth
International, Inc., +1-212-838-1444, for AMDL, Inc. Web site:
http://www.amdl.com/ http://www.sgi-ir.com/
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From May 2024 to Jun 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2023 to Jun 2024